Barclays cuts Sabra Health Care REIT stock target to USD 21.00
Published on 10/15/2026 at 20:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTargets dates and trading levels
- Barclays lowered its target from USD 23.00 to USD 21.00 on October 13, 2026.
- Sabra Health Care REIT is estimated to report third-quarter results on November 4, 2026.
- Sabra Health Care REIT stock costs EUR 17.26 at Lang & Schwarz on October 15, 2026 at 8:06 p.m. CEST, while Nasdaq was up 1.02 percent on the day.
- Sabra Health Care REIT had a market capitalization of USD 4.9 billion and a P/E ratio of 73.80 on October 15, 2026.
Barclays lowered its Sabra Health Care REIT target from USD 23.00 to USD 21.00 on October 13, 2026, leaving 8.42 percent upside to the USD 19.37 Nasdaq price. According to Markets Insider, Barclays retained an Equal Weight rating. At Lang & Schwarz, Sabra Health Care REIT was trading at EUR 17.26 on October 15, 2026 at 8:06 p.m. CEST.
November date sets the next marker
Sabra Health Care REIT is estimated to report third-quarter results on November 4, 2026, after the US market closes. The conference call is scheduled for 4:00 p.m. ET. MarketBeat identifies the date as an estimate based on the company reporting schedule.
Price position in the healthcare REIT group
On Nasdaq, the stock was last at USD 19.37 on October 15, 2026 at 2:14 p.m. EDT. The 52-week range was USD 17.17 to USD 22.77, putting the price 12.81 percent above the low and 14.93 percent below the high. Trading volume was 785,286 shares against an average of 2,607,696 shares.
Sabra reported USD 230.11 million in revenue for the second quarter of 2026 and diluted earnings per share of minus USD 0.10. The company describes itself as a healthcare real estate owner and investor serving the United States and Canada, with its investor-relations page listing second-quarter 2026 results.
Comparison with peers
Sabra Health Care REIT (Nasdaq, USD): plus 1.02 percent, P/E 73.80, market capitalization USD 4.9 billion
Welltower (NYSE, USD): plus 0.82 percent, P/E 123.92, market capitalization USD 168.7 billion
Ventas (NYSE, USD): plus 1.29 percent, P/E 158.17, market capitalization USD 43.8 billion
Euro quote and US session
Sabra Health Care REIT traded at EUR 17.26 at Lang & Schwarz on October 15, 2026 at 8:06 p.m. CEST. Nasdaq was up 1.02 percent on the day, while the company remained below its 52-week high of USD 22.77.
The further course of trading is shown by the continuously updated real-time quote of Sabra Health Care REIT stock.
Sabra Health Care REIT market data
- Company: Sabra Health Care REIT, Inc.
- ISIN: US78573L1061
- Ticker: SBRA
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 15, 2026, 8:06 p.m. CEST): EUR 17.26
- Daily change on Nasdaq: plus 1.02 percent (October 15, 2026)
- Market capitalization: USD 4.9 billion (as of October 15, 2026)
- 52-week range: USD 17.17-22.77 (as of October 15, 2026)
- Sector / Industry: Real Estate / Healthcare Facilities REIT
Market context: Market report Nasdaq Composite.
